• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Detection of residual lesions and metastases of medullary thyroid cancer].

作者信息

Murat A

机构信息

Clinique d'Endocrinologie, Maladies Métaboliques, Nutrition, Hôtel Dieu, Nantes.

出版信息

Ann Endocrinol (Paris). 1996;57(1):27-32.

PMID:8734286
Abstract

Persistent hypercalcitoninemia represents a frequent situation particularly in case of inadequate surgery of medullary throid carcinoma (MTC). This event conducts to a surgical re-exploration after excluding the presence of distant metastases. After adequate initial surgical treatment the localisation of the residual or recurrent tumor tissue is often difficult with conventional imaging techniques. Immunoscintigraphy and selective venous sampling for calcitonin measurements have a good diagnostic sensitivity for cervical or mediastinal localisations and also for distant metastases. However complete remissions are not the rule after cervical and/or mediastinal reintervention which are proposed to patients who are free of distant metastases. This underlines the necessity of early diagnosis of MTC and adequate first neck operation.

摘要

相似文献

1
[Detection of residual lesions and metastases of medullary thyroid cancer].
Ann Endocrinol (Paris). 1996;57(1):27-32.
2
[Medullary thyroid carcinomas: persistent hypercalcitoninemia after surgery, reoperations-results].[甲状腺髓样癌:术后持续性降钙素血症、再次手术的结果]
Ann Chir. 2003 Jun;128(5):289-92. doi: 10.1016/s0003-3944(03)00093-2.
3
Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.持续性或复发性甲状腺髓样癌患者再次手术及定位研究的长期结果
Arch Surg. 2000 Aug;135(8):895-901. doi: 10.1001/archsurg.135.8.895.
4
Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery.借助免疫闪烁显像和放射免疫导向手术成功手术切除甲状腺髓样癌复发的隐匿性转移灶。
Clin Cancer Res. 2000 Feb;6(2):363-71.
5
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.用于持续性甲状腺髓样癌定位的选择性静脉采样导管插入术。
Br J Cancer. 1994 Jun;69(6):1141-4. doi: 10.1038/bjc.1994.224.
6
Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.散发性髓样甲状腺癌中颈侧区淋巴结转移的术前临床及超声预测因素。
Thyroid. 2018 Mar;28(3):362-368. doi: 10.1089/thy.2017.0514. Epub 2018 Feb 15.
7
Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings.放射性同位素引导手术在嗜铬细胞瘤和复发性甲状腺髓样癌患者中的应用:术前和术中肿瘤定位与组织病理学结果的比较。
Cancer. 2001 Jul 15;92(2):263-70. doi: 10.1002/1097-0142(20010715)92:2<263::aid-cncr1318>3.0.co;2-z.
8
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?抗癌胚抗原抗体与生长抑素类似物在检测转移性甲状腺髓样癌中的比较:癌胚抗原和生长抑素受体表达是预后因素吗?
Cancer. 1997 Dec 15;80(12 Suppl):2436-57. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2436::aid-cncr16>3.3.co;2-3.
9
Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.正电子发射断层扫描(18氟脱氧葡萄糖正电子发射断层扫描,18FDG-PET)在检测甲状腺髓样癌转移灶中的应用
Endokrynol Pol. 2006 Jul-Aug;57(4):452-5.
10
Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT.术后应用(11)C-蛋氨酸 PET/CT 对甲状腺髓样癌进行定位:与(18)F-FDG PET/CT 的比较。
Endocr J. 2010;57(12):1045-54. doi: 10.1507/endocrj.k10e-258. Epub 2010 Oct 22.

引用本文的文献

1
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient.MEN2A患者嗜铬细胞瘤的不寻常临床表现。
J Endocrinol Invest. 2002 Jan;25(1):53-7. doi: 10.1007/BF03343961.